Skip to main navigation Skip to search Skip to main content

L1CAM in human cancer

  • Peter Altevogt
  • , Kai Doberstein
  • , Mina Fogel

Research output: Contribution to journalReview articlepeer-review

158 Scopus citations

Abstract

L1 cell adhesion molecule (L1CAM) is one of the first neural adhesion molecules described with important functions in the development of the nervous system. Subsequent work discovered that L1CAM is expressed in many human cancers and is often associated with bad prognosis. This is most likely due to the motility and invasion promoting function of L1CAM. Here, we describe the path L1CAM has taken from a neural adhesion molecule to a recognized tumor antigen. We summarize the literature on L1CAM expression in cancers and pre-cancerous lesions. We focus on the genetic elements required for its re-expression and highlight preclinical studies for targeted therapy. The data suggest that L1CAM is a valuable diagnostic/prognostic marker and an attractive target for the therapy of several human cancers.

Original languageEnglish
Pages (from-to)1565-1576
Number of pages12
JournalInternational Journal of Cancer
Volume138
Issue number7
DOIs
StatePublished - 1 Apr 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • L1CAM
  • immunohistochemistry
  • therapy model
  • tumor therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'L1CAM in human cancer'. Together they form a unique fingerprint.

Cite this